The United States arthroscopy and soft tissue market was valued at more than $2.1 billion in 2010 and is expected to reach $4.2 billion by 2017. The growth may be driven by product innovation and an increase in arthroscopic procedures following the recession. Last year, there were more than 4 million arthroscopies performed in the United States.
Smith & Nephew and Arthrex are current leaders in hip arthroscopy, followed by Stryker which recently launched a platform that is expected to gain market share.
The rotator cuff suture anchor market is also expected to grow significantly due to the shift toward double-row repair, price-premium knotless suture anchors and biocomposite anchors. The biocomposite market is expected to grow six-fold by 2017.
Read the release on the arthroscopy and soft tissues market.
Related Articles on the Orthopedic Device Market:
Orthopedic Device Company CEOs Expect Market Growth in 2011
Millennium Research Group: Orthopedic Extremities Market to Generate $46B by 2015
Global Vertebral Compression Fracture Device Market to Reach $1.4B by 2015
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
